Neuroinflammation in amyotrophic lateral sclerosis

5Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Neuroinflammation, characterized by activated astrocytes and microglia, infiltrated T cells, and the subsequent production of inflammatory mediators, is a pathological hallmark of amyotrophic lateral sclerosis (ALS). Since microglia produce proinflammatory cytokines and other neurotoxic or protective molecules and astrocytes reduce their glutamate uptake, these functional changes in glial cells are considered to play important roles in neurodegeneration. However, what regulates the neuroprotective response in neuroinflammation of ALS has not been clarified. In this regard, we identify astrocyte-derived transforming growth factor-β (TGF-β) as a negative regulator of neuroprotective inflammatory response by microglia and T cells. Understanding the pathomechanism of neuroinflammation of ALS leads to the development of new therapies that target glial cells and T cells.

Cite

CITATION STYLE

APA

Endo, F., & Yamanaka, K. (2014). Neuroinflammation in amyotrophic lateral sclerosis. In Clinical Neurology (Vol. 54, pp. 1128–1131). Societas Neurologica Japonica. https://doi.org/10.5692/clinicalneurol.54.1128

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free